Suzhou Ribo Life Science - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeSuzhou Ribo Life Science
Suzhou Ribo Life Science logo

Suzhou Ribo Life Science

0 followers

About Suzhou Ribo Life Science

Suzhou Ribo Life Science is a China-based biotechnology company focused on RNA interference (RNAi) therapies and oligonucleotide drug development. It has established an end-to-end, internally controlled platform for oligonucleotide drug discovery and development, including liver-targeted delivery technologies and chemical modification platforms to advance multiple product candidates. The company concentrates on cardiovascular, metabolic, liver, kidney, and rare diseases, with a global expansion strategy and a pipeline aimed at progressing RNAi therapeutics from early research to clinical use.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Facts

HQ Location

China

Founded

2007

Employees

11 - 50

Status

Private

Website

https://ribolia.com